Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence

Dito Anurogo
International Journal of Health and Medicine 📅 2025 Vol 2, No 1 🔗 DOI: 10.62951/ijhm.v2i1.126
Abstract
The Next-Gen Global Health 6.0 initiative offers an integrative model employing genomics, nano-immunotherapies, and artificial intelligence (AI) to address the escalating complexity of global health issues, particularly the convergence of infectious and chronic diseases. This framework advances precision medicine by integrating real-time genomic surveillance with AI algorithms, enabling timely prediction and response to outbreaks, as well as tailored therapeutic approaches. Nano-immunotherapies play a critical role in modulating immune responses with high specificity, especially in chronic infections and diseases resistant to conventional treatments. Through these synergistic technologies, the Next-Gen Global Health 6.0 approach aims to transcend traditional healthcare boundaries, offering scalable, data-driven interventions that are adaptable to varying resource levels worldwide. Emphasizing accessibility and equity, this framework highlights the necessity for innovative health policies and interdisciplinary collaboration to optimize deployment in underserved regions, ultimately contributing to sustainable, resilient healthcare systems prepared for evolving global health challenges.
Keywords
Genomics; Infectious Diseases; Chronic Diseases; Precision Medicine; Global Health
How to Cite

Dito Anurogo (2025). Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence. International Journal of Health and Medicine, 2(1). https://doi.org/10.62951/ijhm.v2i1.126

Dito Anurogo, "Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence," International Journal of Health and Medicine, vol. 2, no. 1, 2025.

Dito Anurogo. "Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence." International Journal of Health and Medicine, vol. 2, no. 1, 2025.

Dito Anurogo. "Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence." International Journal of Health and Medicine 2, no. 1 (2025).

Dito Anurogo (2025) 'Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence', International Journal of Health and Medicine, 2(1). doi: 10.62951/ijhm.v2i1.126.

Dito Anurogo. Next-Gen Global Health 6.0: Integrative Genomics, Nano-Immunotherapies, and AI for Infectious and Chronic Disease Convergence. International Journal of Health and Medicine. 2025;2(1).

Artikel Terkait

Determination of Institutional Factors on The Effectiveness of The Pesiar Program in Promoting Universal Health Coverage in Semarang City

Upik Handayani; Aris Toening W; Permadi Mulajaya

Lifestyle Patterns Among People Living With HIV in Peer Support Groups: Socioeconomic and Clinical Predictors of Health-Promoting Behaviors

Sri Handayani; Susana Nurtanti

Mouse Models in Autoimmune Disease Studies: Reproducibility and Clinical Applications

Muhammad Faldy Abdul Aziz; Malika Adira Hasri; Nany Hairunisa; Nor Azlina Khalil; Rodiah Mohd Radzi; Dyah Ayu Woro Setyaningrum

Factors Associated with Bullying Behavior among Adolescents in a Junior High School

Lia Dwi Jayanti; Rahma Wulan Safitri; Tri Wiji Lestari

Childhood Stunting as a Public Health Problem and its Prevention Interventions: A Literature Review

Atalia Pili Mangngi

Influence of Healthscapes and Mimetic Desire on Birthing Place Choice Mediated by Perceived Value

Namira Azzahra; MF Arrozi Adhikara; Rokiah Kusumapradja
Tren Sitasi Jurnal